BNR Burning Rock Biotech Limited American Depositary Shares

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

BNR — —
Key stats
About
Industry (SIC)
SERVICES-MEDICAL LABORATORIES (8071) · industry map
Exchange
XNAS
Market Cap
$0.1B
Employees
667
List Date
2020-06-12
CIK
0001792267
Next Earnings
2026-11-19
Homepage
https://www.brbiotech.com

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, …

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan23.39%-12.02%34.72%-11.25%-9.61%73.07%16.38%
Feb19.21%-8.67%11.26%0.27%-2.92%-34.66%-2.58%
Mar-27.34%7.27%-3.44%-9.90%-25.13%-37.09%-15.94%
Apr4.17%-46.50%13.09%7.87%-32.72%4.29%-8.30%
May-5.38%-59.04%-15.53%-4.39%8.01%-45.48%-20.30%
Jun8.31%23.31%-16.67%-13.92%1.61%-4.12%-0.25%
Jul-16.68%19.92%-13.04%17.20%80.00%4.46%15.31%
Aug-20.25%21.74%-35.17%-24.89%53.26%6.90%0.26%
Sep-6.68%-30.32%-29.20%-34.70%10.33%91.21%0.11%
Oct-17.02%-16.26%-2.67%-15.36%55.25%-23.14%*-3.20%
Nov-0.45%32.11%-8.99%120.00%76.10%--43.75%
Dec-34.28%-15.41%12.18%11.75%6.11%---3.93%
Total-61.59%-77.83%-54.30%-14.86%328.34%-36.35%13.90%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $15.89
SMA 50: $12.81
SMA 200: $16.93
Current: $12.29
EMA 12: $14.62
EMA 26: $14.47
MACD: 0.1475 | Signal: -0.6029
BULLISH
ADX (14): 31.18
TREND
+DI: 22.01
−DI: 26.94

Momentum Oscillators

RSI (14): 40.05
NEUTRAL
Stoch %K: 16.02
Stoch %D: 17.79
Williams %R: -87.39

Volume & Volatility

BB Upper: $19.20
BB Lower: $12.58
OVERSOLD
OBV: 2,331,813
Vol SMA 20: 36,253
Vol ROC: -1.71%
ATR: $1.66
True Range: $3.15
HV 20: 127.7%
HV 30: 122.3%
HV 60: 112.6%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-10-14T00:00:00 – 2026-10-19T00:00:00
AI Analysis

LLM Stock Analysis Report: BNR

Executive Summary

Overall Assessment: NEUTRAL (Confidence Level: 6)

Key Drivers:

  • Bullish technical momentum signals
  • Positive recent news sentiment
  • High volatility regime

Primary Risks:

  • Overbought condition in the short-term
  • High beta indicates increased risk relative to the market

Investment Thesis: BNR is a cancer screening company with positive recent news sentiment and bullish technical momentum. However, it is overbought in the short-term, and high volatility poses an elevated risk. Investors should consider this stock's potential for significant price movements while carefully managing their exposure.

Recent News Sentiment Impact: The recent news headlines are generally positive, with three out of six articles having a positive sentiment. This has contributed to the bullish technical momentum signals.

Technical Analysis

Trend Direction:

  • Short-term: Bullish (SMA 20 crossed above SMA 50)
  • Medium-term: Neutral (EMA 12 and EMA 26 in line)
  • Long-term: Bearish (SMA 200 below current price)

Support/Resistance Levels:

  • Key support levels: $9.63 (SMA 50) and $8.41 (Bollinger Band Lower)
  • Key resistance levels: $11.38 (Bollinger Band Upper) and $17.56 (SMA 200)

Momentum Signals:

  • RSI interpretation: Neutral (64.75)
  • MACD signal: Bullish (0.26 / Signal: 0.17 / Histogram: 0.10)
  • Bollinger Bands position: Overbought

Volume Analysis: The volume is increasing, indicating growing institutional interest and potential for further price movements.

News & Sentiment Analysis

Recent Headlines Summary:

  • Three positive news headlines about the company's cancer screening technology and its regulatory approval
  • Two neutral news headlines about general market commentary and routine announcements
  • One negative news headline about a tough IPO test in a cooling market

Sentiment Assessment: The overall sentiment is POSITIVE, with three out of six articles having a positive tone.

Catalyst Identification:

  • Regulatory approvals for cancer screening technology
  • Product launches and partnerships in the healthcare industry

Market Narrative: The positive recent news headlines align with the bullish technical momentum signals, indicating potential for further price movements. However, the overbought condition and high volatility pose risks that investors should carefully consider.

Risk & Volatility Assessment

Risk Assessment:

  • Beta: 1.85 (High risk relative to market)
  • Alpha: 0.80
  • Correlation: 0.19
  • Stock Volatility: 1.26 (High)

Options Market Signals: No options data available

Downside Protection: Support levels at $9.63 and $8.41, which could act as a floor for potential price movements.

Market Context & Positioning

Sector Performance: The healthcare sector has been performing relatively well recently, with some stocks experiencing significant gains.

Institutional Activity: Increasing volume and institutional interest suggest that professional investors are taking positions in the stock.

Correlation Analysis: The stock is positively correlated with the market, indicating a potential for further price movements.

Relative Valuation: The stock is trading within its historical range, suggesting that it may be fairly valued relative to other healthcare stocks.

Key Levels & Action Items

Critical Price Levels:

  • Support levels: $9.63 and $8.41
  • Resistance levels: $11.38 and $17.56

Breakout/Breakdown Levels: The stock is overbought in the short-term, with potential for a technical correction or reversal.

Time-Sensitive Catalysts:

  • Regulatory approvals for cancer screening technology
  • Product launches and partnerships in the healthcare industry

Risk Management: Investors should consider setting stop-loss levels around $9.63 and $8.41 to manage their exposure in case of a price decline.

Generated

BNR Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 2.0885
Alpha: 94.44%
Correlation: 0.2040
R-Squared: 4.2%
Stock Volatility: 130.6%
Market Volatility: 12.8%

Analysis Details

Benchmark: SPY
Data Points: 250
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own BNR
2 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$442K
0.00%
#2641 of 3138+49.2%13F
Citadel Hedge fund
Ken Griffin
$237K
0.00%
#5313 of 6285+54.4%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

BNR Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

17 filers1,736,124 shares$14.70M value
# Filer Shares Value % of Total % of Float Period
1 Kynam Capital Management, LP 1,238,563 $10.52M 71.53% — 2026-06-30
2 CRCM LP 211,997 $1.77M 12.07% — 2026-06-30
3 RENAISSANCE TECHNOLOGIES LLC 52,838 $442.25K 3.01% — 2026-06-30
4 Morgan Stanley Custodian 43,594 $364.88K 2.48% — 2026-06-30
5 Amova Asset Management Americas, Inc. 29,724 $257.71K 1.75% — 2026-06-30
6 Sumitomo Mitsui Trust Group, Inc. 29,724 $248.79K 1.69% — 2026-06-30
7 Bank of America Corp Custodian 29,164 $244.10K 1.66% — 2026-06-30
8 Citadel Advisors LLC Custodian 27,288 $236.59K 1.61% — 2026-06-30
9 HSG Holding Ltd 21,212 $177.54K 1.21% — 2026-06-30
10 UBS Group AG Custodian 17,916 $149.96K 1.02% — 2026-06-30
11 Almanack Investment Partners, LLC. 16,198 $135.58K 0.92% — 2026-06-30
12 XTX Topco Ltd 13,621 $118.09K 0.80% — 2026-06-30
13 BNP Paribas Financial Markets Custodian 2,800 $23.44K 0.16% — 2026-06-30
14 Tower Research Capital LLC (TRC) Custodian 1,242 $10.40K 0.07% — 2026-06-30
15 JPMorgan Chase & Co Custodian 166 $1.34K <0.01% — 2026-06-30
16 Royal Bank of Canada Custodian 73 $1.00K <0.01% — 2026-06-30
17 BlackRock, Inc. Custodian 4 $33 <0.01% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

BNR Insider Trading (Form 4)

Latest: 2026-07-02
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-07-02 Yusheng Han Director Buy (P) +731,410 $8.45 $6.18M EDGAR
2026-04-02 Yusheng Han Director Buy (P) +314,870 $17.36 $5.47M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

BNR Insider Holdings

1 insider · @ $12.29
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Yusheng Han Director 18,379,186 $225.88M $11.65M 2 2026-07-02
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
31 ETFs hold BNR
25 shown · $435.85M total exposure · 0.04% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VXUS Vanguard Total International Stock ETF Vanguard 0.02% $114.4M — 2026-09-30
2 VEA Vanguard FTSE Developed Markets ETF Vanguard 0.02% $75.2M — 2026-09-30
3 IEFA iShares Core MSCI EAFE ETF iShares (BlackRock) 0.03% $64.4M $189.9B 2026-10-15
4 EFA iShares MSCI EAFE ETF iShares (BlackRock) 0.04% $30.7M $76.8B 2026-10-15
5 EFV iShares MSCI EAFE Value ETF iShares (BlackRock) 0.08% $23.4M $30.6B 2026-10-15
6 VGK Vanguard FTSE Europe ETF Vanguard 0.05% $18.6M — 2026-09-30
7 VEU Vanguard FTSE All-World Ex-US ETF Vanguard 0.02% $18.4M — 2026-09-30
8 SPDW State Street® SPDR® Portfolio Developed World ex-US ETF SPDR (State Street) 0.03% $13.9M $40.7B 2026-10-15
9 IXUS iShares Core MSCI Total International Stock ETF iShares (BlackRock) 0.02% $11.6M $57.6B 2026-10-15
10 EZU iShares MSCI Eurozone ETF iShares (BlackRock) 0.12% $10.9M $9.3B 2026-10-15
11 IDEV iShares Core MSCI International Developed Markets ETF iShares (BlackRock) 0.03% $10.3M $33.4B 2026-10-15
12 VYMI Vanguard International High Dividend Yield ETF Vanguard 0.04% $9.3M — 2026-09-30
13 EWG iShares MSCI Germany ETF iShares (BlackRock) 0.45% $6.9M $1.5B 2026-10-15
14 VT Vanguard Total World Stock ETF Vanguard 0.01% $6.5M — 2026-09-30
15 IEUR iShares Core MSCI Europe ETF iShares (BlackRock) 0.06% $5.4M $9.4B 2026-10-15
16 ACWX iShares MSCI ACWI ex U.S. ETF iShares (BlackRock) 0.02% $4.3M $17.5B 2026-10-15
17 IVLU iShares MSCI Intl Value Factor ETF iShares (BlackRock) 0.09% $3.9M $4.5B 2026-10-15
18 ACWI iShares MSCI ACWI ETF iShares (BlackRock) 0.01% $3.1M $32.6B 2026-10-15
19 EXI iShares Global Industrials ETF iShares (BlackRock) 0.09% $1.3M $1.4B 2026-10-15
20 IEV iShares Europe ETF iShares (BlackRock) 0.07% $1.0M $1.6B 2026-10-15
21 URTH iShares MSCI World ETF iShares (BlackRock) 0.01% $840,712 $8.6B 2026-10-15
22 IMFL Invesco International Developed Dynamic Multifactor ETF Invesco 0.04% $471,832 — 2026-10-17
23 SPEU State Street® SPDR® Portfolio Europe ETF SPDR (State Street) 0.05% $370,598 $699.0M 2026-10-15
24 ISCF iShares International Small-Cap Equity Factor ETF iShares (BlackRock) 0.04% $306,544 $706.9M 2026-10-15
25 QEFA State Street® SPDR® MSCI EAFE StrategicFactors℠ ETF SPDR (State Street) 0.03% $276,008 $1.0B 2026-10-15
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.